Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial
Author
Bourgeois, FlorenceDoshi, Peter
Hong, Kyungwan
Jefferson, Tom
Jones, Mark
Lee, Haeyoung
Rowhani-Farid, Anisa
Shamseer, Larissa
Spence, O'Mareen
Date
2020-11-04Journal
mSpherePublisher
American Society for MicrobiologyType
Other
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/14101ae974a485f413a2113503eed53cd6c53
10.1128/mSphere.00770-20
Scopus Count
Collections
Related articles
- Reply to Bourgeois et al., "Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial".
- Authors: Garland SM, Steben M
- Issue date: 2020 Nov 4
- A reactogenic "placebo" and the ethics of informed consent in Gardasil HPV vaccine clinical trials: A case study from Denmark.
- Authors: Tomljenovic L, McHenry LB
- Issue date: 2024
- Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa.
- Authors: Mugo N, Ansah NA, Marino D, Saah A, Garner EI
- Issue date: 2015
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial.
- Authors: Leung TF, Liu AP, Lim FS, Thollot F, Oh HM, Lee BW, Rombo L, Tan NC, Rouzier R, Friel D, De Muynck B, De Simoni S, Suryakiran P, Hezareh M, Folschweiller N, Thomas F, Struyf F
- Issue date: 2015
- Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants.
- Authors: Murata S, Shirakawa M, Sugawara Y, Shuto M, Sawata M, Tanaka Y
- Issue date: 2020 Dec